recor-homebanner-revised

If you have Hypertension, you are not alone.

Over 1 billion people have hypertension. To learn more, CLICK HERE.

Renal denervation is a potential new way to treat hypertension.  ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation.

Learn more about our technology

Radiance Study

The RADIANCE Global Program

The RADIANCE Global Program is an international, multicenter, first-of-its-kind initiative designed to explore the benefits of renal denervation in hypertension. The RADIANCE studies are double-blind, randomized, sham-controlled trials designed to provide additional information about the ability of the Paradise® Renal Denervation System to treat high blood pressure.


RADIANCE-HTN is enrolling for its TRIO cohort, which will evaluate how the Paradise System reduces blood pressure in patients with resistant hypertension, despite being on medication. RADIANCE-HTN is currently enrolling patients with uncontrolled blood pressure on 3 or more medications.

Am I a candidate?

More detailed study information can be found on clinicaltrials.gov


RADIANCE-II is a pivotal trial, currently enrolling patients, to study the safety and effectiveness of the Paradise System to reduce blood pressure in patients with hypertension, in the absence of antihypertensive medications. RADIANCE-II is currently enrolling patients with uncontrolled blood pressure on 0-2 medications.

Am I a candidate?

More detailed study information can be found on clinicaltrials.gov